Skip to main content

Table 1 Mean and Median Counts of Indicators of Overuse Across Regions, 2010 months 1–6 (N = 422 regions)

From: Systemic overuse of health care in a commercially insured US population, 2010–2015

Overuse Indicator

Per 1000

Mean

Median

Interquartile Range

Stress echocardiography in symptomatic or ischemic equivalent acute chest paina

52.4

36.6

0.0

72.8

Laminectomy or spinal fusion

0.6

0.6

0.4

0.8

Hysterectomy for benign disease

3.5

3.3

2.5

4.3

Fiberoptic laryngoscopy for sinusitis diagnosisa

2.4

1.6

0.7

3.0

Nasal endoscopy for sinusitis diagnosisa

21.3

16.4

9.5

28.5

Routine monitoring of digoxin in patients with congestive heart failure

18.7

16.6

9.6

23.5

EEG monitoring in individuals presenting with syncopea

59.6

55.3

39.2

75.4

Serological tests for Helicobacter pylori

4.2

4.1

2.8

5.4

MRI in adults with mild traumatic brain injurya

22.9

20.8

7.5

31.3

PET, CT, and radionuclide bone scan in individuals with low-risk prostate cancer

112

105

80.3

135

Traction for low back pain

222

216

169

271

Screening for asymptomatic carotid artery stenosis in the general adult population

1.3

1.1

0.8

1.6

Preoperative chest radiography in the absence of a clinical suspiciona

135

118

89.6

165

Tumor marker studies in asymptomatic women with previously treated breast cancer

289

272

165

386

Diagnostic tests, such as immunoglobulin testing, in the evaluation of allergya

12.2

10.5

5.9

16.7

Sinus CT for uncomplicated acute rhinosinusitisa

1.1

0.9

9.0

1.4

MRI lumbar spine for low back paina

491

493

454

530

Thorax CT use with and without contrasta

70.2

47.4

22.9

94.0

Abdomen CT use with and without contrasta

182

136

90.6

259

  1. CT Indicates computed tomography, EEG Electroencephalography, MRI Magnetic resonance imaging, PET Positron emission tomography
  2. aCount is per 1000 eligible episodes rather than per 1000 beneficiaries